Alpha Tau Medical to Attend March Investor Conferences
Ticker: DRTSW · Form: 6-K · Filed: Feb 27, 2025 · CIK: 1871321
| Field | Detail |
|---|---|
| Company | Alpha Tau Medical Ltd. (DRTSW) |
| Form Type | 6-K |
| Filed Date | Feb 27, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: investor-relations, conference-participation
TL;DR
Alpha Tau Medical is hitting investor conferences in March, expect more buzz.
AI Summary
Alpha Tau Medical Ltd. announced on February 27, 2025, that it will participate in upcoming investor conferences in March. The company is a medical device company focused on cancer treatment. This announcement was made via a press release attached to a Form 6-K filing.
Why It Matters
Participation in investor conferences can lead to increased visibility and potential investment, which is crucial for a medical device company seeking to advance its cancer treatment technology.
Risk Assessment
Risk Level: low — The filing is a routine announcement of participation in investor conferences, with no new financial or operational information that would significantly alter risk.
Key Players & Entities
- Alpha Tau Medical Ltd. (company) — Registrant
- February 27, 2025 (date) — Announcement Date
- March 2025 (date) — Conference Month
FAQ
What is the purpose of Alpha Tau Medical Ltd.'s Form 6-K filing?
The Form 6-K filing is to report that Alpha Tau Medical Ltd. issued a press release on February 27, 2025, announcing its participation in investor conferences in March.
What is the title of the press release mentioned in the filing?
The press release is titled 'Alpha Tau to Participate in March Investor Conferences.'
When was the press release issued?
The press release was issued on February 27, 2025.
What is Alpha Tau Medical Ltd.'s principal executive office address?
The principal executive offices are located at Kiryat HaMada St. 5, Jerusalem, Israel, 9777605.
Is Alpha Tau Medical Ltd. required to file annual reports under Form 20-F or Form 40-F?
Alpha Tau Medical Ltd. indicates it files annual reports under Form 20-F.
Filing Details
This Form 6-K (Form 6-K) was filed with the SEC on February 27, 2025 regarding Alpha Tau Medical Ltd. (DRTSW).